ARCHIVES

DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be?

This article is from The Cancer Letter archive.

Vol. 12 No. 37 | September 26, 1986

Download PDF Visit The Full Archive

Related Articles

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

Byrd Permits NCI to Reallocate WVU Money

June 21, 1985

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

Research Suggestions Considered By DCBD Diagnostic Group

July 11, 1980

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000